Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946906 | IM / LA |
pt developed puss at the injection site with tenderness, swelling with itchy rash and blisters. Pt has no fever only a local reaction that seems to be improving using calamine lotion. She will follow up with physician if symptoms don't subside.
none
HBP, obesity, sleep apnea, reflux, HSV
none
morphine, opioids